tiprankstipranks
Psyence Group (TSE:PSYG)
CNQX:PSYG
Canadian Market

Psyence Group (PSYG) Stock Price & Analysis

3 Followers

PSYG Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.15
Previous CloseC$0.03
Volume8.00K
Average Volume (3M)84.30K
Market Cap
C$2.75M
Enterprise ValueC$2.58M
Total Cash (Recent Filing)C$213.45K
Total Debt (Recent Filing)C$43.09K
Price to Earnings (P/E)-0.5
Beta-0.24
Jul 02, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding137,438,182
10 Day Avg. Volume253,270
30 Day Avg. Volume84,296
Standard Deviation0.23
R-Squared0.00156
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)6.38
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio34.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.42%0.00%0.00%97.58%
0.00% Other Institutional Investors
97.58% Public Companies and
Individual Investors

PSYG FAQ

What was Psyence Group’s price range in the past 12 months?
Psyence Group lowest stock price was C$0.01 and its highest was C$0.15 in the past 12 months.
    What is Psyence Group’s market cap?
    Currently, no data Available
    When is Psyence Group’s upcoming earnings report date?
    Psyence Group’s upcoming earnings report date is Jul 02, 2024 which is in 62 days.
      How were Psyence Group’s earnings last quarter?
      Psyence Group released its earnings results on Feb 28, 2024. The company reported C$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.003.
        Is Psyence Group overvalued?
        According to Wall Street analysts Psyence Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Psyence Group pay dividends?
          Psyence Group does not currently pay dividends.
          What is Psyence Group’s EPS estimate?
          Psyence Group’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Psyence Group have?
          Psyence Group has 137,438,190 shares outstanding.
            What happened to Psyence Group’s price movement after its last earnings report?
            Psyence Group reported an EPS of C$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Psyence Group?
              Currently, no hedge funds are holding shares in TSE:PSYG
              ---

              Psyence Group Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -79.16%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -48.64%
              Trailing 12-Months

              Company Description

              Psyence Group

              Psyence Group Inc is a science-led psychedelic platform led by experts in neurology, neuroscience, and drug development. It builds and operates federally licensed commercial psilocybin cultivation and production facilities.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Numinus Wellness
              GreenBank Capital
              Strategem Capital
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis